The Exercise Mode works on a target range of 140–160 mg/dL, allowing a reduced risk of hypoglycemia; when the predicted glucose value is <80 mg/dL the pump suspends the delivery of basal insulin. The gene discussed is INS; the disease is Hypoglycemia.